We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.59B
AUM Growth
+$160M
Cap. Flow
-$54.6M
Cap. Flow %
-3.43%
Top 10 Hldgs %
16.55%
Holding
226
New
31
Increased
63
Reduced
63
Closed
27

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$19M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$16.3M
3
AMRS
Amyris Inc.
AMRS
+$14.3M
4
ESTA icon
Establishment Labs
ESTA
+$12.8M
5
SQSP
Squarespace, Inc.
SQSP
+$9.51M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$20M
2
NVCR icon
NovoCure
NVCR
+$14.8M
3
SEER icon
Seer Inc
SEER
+$14.5M
4
JBLU icon
JetBlue
JBLU
+$14.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 44.51%
2 Technology 13.21%
3 Financials 6.93%
4 Consumer Discretionary 6.6%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
26
Insulet
PODD
$9.66B
$19.7M 1.24%
71,754
+2,101
+3% +$571K
LSCC icon
27
Lattice Semiconductor
LSCC
$18.3B
$19.4M 1.22%
345,989
-53,480
-13% -$2.74M
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$19.2M 1.2%
+118,591
New +$19M
NVCR icon
29
NovoCure
NVCR
$1.83B
$18.9M 1.18%
85,027
-76,110
-47% -$14.8M
ESTC icon
30
Elastic
ESTC
$7.27B
$18.3M 1.15%
125,608
+25,941
+26% +$3.24M
TPTX
31
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$17.5M 1.1%
224,876
+6,029
+3% +$446K
OMIC
32
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$17.3M 1.09%
+20,991
New +$16.3M
CALY
33
Callaway Golf Company
CALY
$3.1B
$16.6M 1.04%
491,614
-9,350
-2% -$301K
TIL icon
34
Instil Bio
TIL
$49.4M
$16.5M 1.03%
42,641
+15,162
+55% +$5.62M
GH icon
35
Guardant Health
GH
$21.1B
$15.8M 0.99%
127,223
-27,284
-18% -$3.67M
KALV
36
DELISTED
KalVista Pharmaceuticals
KALV
$15.6M 0.98%
650,903
+56,773
+10% +$1.49M
KTB icon
37
Kontoor Brands
KTB
$4.36B
$15.2M 0.96%
270,057
+21,855
+9% +$1.34M
DMTK
38
DELISTED
DermTech, Inc. Common Stock
DMTK
$15.2M 0.95%
365,933
-30,573
-8% -$1.26M
GTLS
39
DELISTED
Chart Industries
GTLS
$15M 0.94%
102,554
-1,336
-1% -$196K
TFII icon
40
TFI International
TFII
$11.3B
$14M 0.88%
153,241
-86,594
-36% -$7.54M
MASS icon
41
908 Devices
MASS
$341M
$13.9M 0.87%
357,858
+48,224
+16% +$2.18M
ESI icon
42
Element Solutions
ESI
$9.37B
$13.8M 0.87%
592,052
+16,418
+3% +$361K
XOM icon
43
ExxonMobil
XOM
$642B
$13.6M 0.85%
215,000
-35,963
-14% -$2.15M
TRIL
44
DELISTED
Trillium Therapeutics Inc.
TRIL
$13.4M 0.84%
1,381,983
+35,230
+3% +$332K
WSC icon
45
WillScot Mobile Mini Holdings
WSC
$4.67B
$13.2M 0.83%
474,095
-49,717
-9% -$1.43M
SPG icon
46
Simon Property Group
SPG
$71.9B
$12.3M 0.77%
94,133
+40,308
+75% +$5.01M
WAL icon
47
Western Alliance Bancorporation
WAL
$8.87B
$12M 0.75%
129,617
-22,288
-15% -$2.21M
IIPR icon
48
Innovative Industrial Properties
IIPR
$1.69B
$12M 0.75%
62,678
+3,911
+7% +$717K
TLIS
49
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$11.8M 0.74%
71,421
-2,006
-3% -$341K
FIVN icon
50
FIVE9
FIVN
$2.17B
$11.6M 0.73%
63,148
+21,418
+51% +$3.69M
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Nicholas Investment Partners held 226 positions worth $1.59B, up 11% from $1.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nicholas Investment Partners withdrew a net $54.6M in Q2 2021, closing 27 positions and reducing 63 holdings. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Mirati Therapeutics, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2021 buy was Mirati Therapeutics, Inc. Common Stock: 118,591 shares worth $19.2M.
  • Nicholas Investment Partners added most to Amyris Inc. in Q2 2021, an estimated $14.3M increase.
  • Nicholas Investment Partners's biggest Q2 2021 reduction was NovoCure, cutting an estimated $14.8M.
  • Nicholas Investment Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 17% of its $1.59B portfolio in Q2 2021.
  • Nicholas Investment Partners opened 31 new positions and closed 27 in Q2 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.59B.

Based on Nicholas Investment Partners's 13F filing for Q2 2021, filed 10 Aug 2021.